FinnCap restated their corporate rating on shares of Omega Diagnostics Group Plc (LON:ODX) in a report issued on Monday morning. They currently have a GBX 28 ($0.35) price objective on the stock.

Shares of Omega Diagnostics Group Plc (LON:ODX) traded down 1.7606% during midday trading on Monday, hitting GBX 17.4375. The stock had a trading volume of 77,564 shares. Omega Diagnostics Group Plc has a one year low of GBX 13.50 and a one year high of GBX 21.00. The firm has a 50 day moving average price of GBX 17.15 and a 200 day moving average price of GBX 17.18. The stock’s market cap is GBX 18.96 million.

About Omega Diagnostics Group Plc

Omega Diagnostics Group PLC is a medical diagnostics company. The Company’s segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.

Receive News & Stock Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related stocks with our FREE daily email newsletter.